ASHLEY BREW: Open Payments
NPI 1235810912 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 26 payments from 10 companies in 2025. Trend: 2023 $158 · 2024 $699 · 2025 $795
Food & beverage: $611Education: $184
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $238 |
| Janssen Biotech, Inc. | 7 | $204 |
| GENZYME CORPORATION | 5 | $114 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $85 |
| ABBVIE INC. | 2 | $50 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| Amgen Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: Bimzelx, TREMFYA, DUPIXENT, RINVOQ, AKLIEF, ACTHAR, CIBINQO, OTEZLA.
Industry payments across TX — which companies pay providers there.
